40 results
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
21 Dec 20
Regulation FD Disclosure
7:04am
pharmaceuticals company with a passion for innovation and improving the lives of patients, their families and caregivers. In the United States, Servier … Pharmaceuticals is committed to building a robust portfolio, starting with Oncology, with future growth driven by innovation in other areas of unmet medical
DEFA14A
EX-99.1
AGIO
Agios Pharmaceuticals Inc
21 Dec 20
Additional proxy soliciting materials
7:10am
pharmaceuticals company with a passion for innovation and improving the lives of patients, their families and caregivers. In the United States, Servier … Pharmaceuticals is committed to building a robust portfolio, starting with Oncology, with future growth driven by innovation in other areas of unmet medical
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
13 Jan 20
Regulation FD Disclosure
4:32pm
: Focused Innovation. Ambitious Development. Transformative Treatments for Patients Across Three Focus Areas. NOW CASH FLOW POSITIVE 2025 FINANCIAL … activator, AG-946 Achieve at least 1 new development candidate
AGIOS 2025 VISION: Focused Innovation. Ambitious Development. Transformative Treatments
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
12 Jun 20
Entry into a Material Definitive Agreement
7:04am
in acquiring pharmaceutical royalties. Royalty Pharma funds innovation in life sciences both directly and indirectly: directly when it partners with life
DEFA14A
AGIO
Agios Pharmaceuticals Inc
12 Jan 21
Additional proxy soliciting materials
5:15pm
REIMAGINING OUR FUTURE 14REIMAGINING OUR FUTURE 14
Focused Innovation. Ambitious Development. AGIOS TOMORROW Increased Patient Impact. BY LEVERAGING WE … and and commercia commercializa lizat tion ion 15 15Focused Innovation. Ambitious Development. AGIOS TOMORROW Increased Patient Impact. BY LEVERAGING
8-K
EX-99.2
r23s l3nnjnpt
21 Dec 20
Regulation FD Disclosure
7:04am
DEFA14A
EX-99.2
7lcl96lnk32v
21 Dec 20
Additional proxy soliciting materials
7:10am
DEFA14A
ifm6s7
23 Dec 20
Additional proxy soliciting materials
4:52pm
424B4
6r1 cc9hvygo
24 Apr 14
Prospectus supplement with pricing info
12:00am
DEFA14A
5hda2n6ty5fpzc
21 Dec 20
Additional proxy soliciting materials
5:23pm
10-K
nx0wy8gbw9bhp cz9
18 Mar 14
Annual report
12:00am